awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28084683-D8FCF1E0-D8F3-4138-8D32-C6DD74EC2C7D
Q28084683-D8FCF1E0-D8F3-4138-8D32-C6DD74EC2C7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28084683-D8FCF1E0-D8F3-4138-8D32-C6DD74EC2C7D
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors
P2860
Q28084683-D8FCF1E0-D8F3-4138-8D32-C6DD74EC2C7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28084683-D8FCF1E0-D8F3-4138-8D32-C6DD74EC2C7D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ba6302b47276c35413cfc4c21c4fa5e72e93184
P2860
Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events.